Merck KGaA's Q3 profit rises, beats market view

Merck KGaA

13/11/2025 06:00

FRANKFURT, Nov 13 (Reuters) - Merck KGaA MRCG.DE reported on Thursday a slight gain in quarterly operating earnings that beat market expectations, benefiting from legislative changes in South America and the sale of a priority review voucher from the U.S. drugs regulator.

The German maker of pharmaceuticals and specialty materials said third-quarter earnings before interest, tax, depreciation and amortisation (EBITDA), adjusted for special items, gained 3.1% to 1.67 billion euros ($1.95 billion), beating an analyst consensus of 1.56 billion posted on the company's website.

It also forecast adjusted EBITDA for 2025 of between 6 billion and 6.2 billion euros, saying the midpoint of the range was unchanged from its previous guidance.

 ($1 = 0.8575 euros)

 (Reporting by Ludwig Burger; Editing by Himani Sarkar)

 ((ludwig.burger@thomsonreuters.com;))